PureIMS
PrivateLast Round
Grant
Sep 3, 2025
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PureIMS is a clinical-stage pharmaceutical and therapeutic devices company that develops and commercializes inhaled therapies based on its proprietary Cyclops® dry powder inhaler platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PureIMS Comparables
Compare PureIMS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merxin Ltd | 83% | |
| Iconovo AB | 82% | |
| Hovione | 77% | |
PureIMS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 3, 2025 | ||||
| VC Round | Apr 3, 2023 | ||||
| Early Funding | Apr 26, 2019 | ||||
| Seed | Oct 12, 2017 |
PureIMS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boost-UP Foundation | VC Round |
| Carduso Capital | VC Round, Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 8, 4x the trailing average.
- Jul 13, 2026
Open roles increased to 4, representing 33% of headcount.
PureIMS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PureIMS's valuation, stock price, and market status.